Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule.
The retail pharmacies segment dominated the erythropoietin drugs market and accounted for a major part of the overall market share. The ability of retail pharmacies to provide a large customer base for biosimilars coupled with the requirement from anemic patients for EPO drugs as a maintenance therapy is the key contributor to the dominance of this segment in the global market.
The global Erythropoietin Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Erythropoietin Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Erythropoietin Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Erythropoietin Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Erythropoietin Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Segment by Application
Anemia
Kidney Disorders
Other
Table of Contents
Executive Summary
1 Industry Overview of Erythropoietin Drugs
1.1 Definition of Erythropoietin Drugs
1.2 Erythropoietin Drugs Segment by Type
1.2.1 Global Erythropoietin Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Epoetin-alfa
1.2.3 Darbepoetin-alfa
1.2.4 Epoetin-beta
1.2.5 Others
1.3 Erythropoietin Drugs Segment by Applications
1.3.1 Global Erythropoietin Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Other
1.4 Global Erythropoietin Drugs Overall Market
1.4.1 Global Erythropoietin Drugs Revenue (2014-2025)
1.4.2 Global Erythropoietin Drugs Production (2014-2025)
1.4.3 North America Erythropoietin Drugs Status and Prospect (2014-2025)
1.4.4 Europe Erythropoietin Drugs Status and Prospect (2014-2025)
1.4.5 China Erythropoietin Drugs Status and Prospect (2014-2025)
1.4.6 Japan Erythropoietin Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Erythropoietin Drugs Status and Prospect (2014-2025)
1.4.8 India Erythropoietin Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Erythropoietin Drugs
2.3 Manufacturing Process Analysis of Erythropoietin Drugs
2.4 Industry Chain Structure of Erythropoietin Drugs
3 Development and Manufacturing Plants Analysis of Erythropoietin Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Erythropoietin Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Erythropoietin Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Erythropoietin Drugs Production and Capacity Analysis
4.2 Erythropoietin Drugs Revenue Analysis
4.3 Erythropoietin Drugs Price Analysis
4.4 Market Concentration Degree
5 Erythropoietin Drugs Regional Market Analysis
5.1 Erythropoietin Drugs Production by Regions
5.1.1 Global Erythropoietin Drugs Production by Regions
5.1.2 Global Erythropoietin Drugs Revenue by Regions
5.2 Erythropoietin Drugs Consumption by Regions
5.3 North America Erythropoietin Drugs Market Analysis
5.3.1 North America Erythropoietin Drugs Production
5.3.2 North America Erythropoietin Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Erythropoietin Drugs Import and Export
5.4 Europe Erythropoietin Drugs Market Analysis
5.4.1 Europe Erythropoietin Drugs Production
5.4.2 Europe Erythropoietin Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Erythropoietin Drugs Import and Export
5.5 China Erythropoietin Drugs Market Analysis
5.5.1 China Erythropoietin Drugs Production
5.5.2 China Erythropoietin Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Erythropoietin Drugs Import and Export
5.6 Japan Erythropoietin Drugs Market Analysis
5.6.1 Japan Erythropoietin Drugs Production
5.6.2 Japan Erythropoietin Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Erythropoietin Drugs Import and Export
5.7 Southeast Asia Erythropoietin Drugs Market Analysis
5.7.1 Southeast Asia Erythropoietin Drugs Production
5.7.2 Southeast Asia Erythropoietin Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Erythropoietin Drugs Import and Export
5.8 India Erythropoietin Drugs Market Analysis
5.8.1 India Erythropoietin Drugs Production
5.8.2 India Erythropoietin Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Erythropoietin Drugs Import and Export
Summary: Get latest Market Research Reports on Erythropoietin Drugs. Industry analysis & Market Report on Erythropoietin Drugs is a syndicated market report, published as Global Erythropoietin Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Erythropoietin Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.